Sort
326,823 grants matching “clinical trial”
Disease mechanism and therapies for retinal degeneration
$2,160,041Tiansen Li · National Eye Institute · ZIA · FY2025 · EY
Head and Neck Cancer SPORE at the University of Wisconsin
$2,160,041Paul M Harari · University Of Wisconsin-Madison · P50 · FY2020 · DE
Therapeutic Fully Human Monoclonal Antibodies against Vaccina Virus and Smallpox
$2,160,000Shane P Crotty · La Jolla Institute For Immunology · U01 · FY2008 · AI
The Alzheimer's Disease Research Center at the University of California, Irvine
$2,159,993Frank M Laferla · University Of California-Irvine · P50 · FY2015 · AG
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine
$2,159,913Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2013 · AI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine
$2,159,913Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2012 · AI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine
$2,159,913Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2015 · AI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine
$2,159,913Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2014 · AI
TRIP-PCI: PAR1 Pepducin-Based Interventions in Arterial Thrombosis
$2,159,793Athan Kuliopulos · Tufts Medical Center · P50 · FY2012 · HL
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,159,717Frank C Arnett · University Of Texas Hlth Sci Ctr Houston · UL1 · FY2006 · RR
Center for Research on Improving the Treatment of Drug Abuse
$2,159,703Charles P O'Brien · University Of Pennsylvania · P60 · FY2011 · DA
CENTER FOR PSYCHO-ONCOLOGY RESEARCH
$2,158,930University Of Miami Coral Gables · P50 · FY2002 · CA
Selective Targeting of Pancreatic Cancer SPORE
$2,158,912Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
DEVELOPMENT OF A NOVEL DRUG CANDIDATE WITH A FIRST-in-CLASS MECHANISM FOR SMOKING CESSATION, RELAPSE and ABSTINENCE
$2,158,836Nurulain T Zaveri · Astraea Therapeutics, Llc · U01 · FY2019 · DA
NRG Oncology Biospecimen Bank
$2,158,763Richard C Jordan · Nrg Oncology Foundation, Inc. · U24 · FY2018 · CA
SPORE in Prostate Cancer
$2,158,540William J Catalona · Northwestern University At Chicago · P50 · FY2016 · CA
Units for HIV/AIDS Clinical Trials Networks
$2,158,520Michael C Keefer · University Of Rochester · UM1 · FY2012 · AI
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
$2,158,371David I Watkins · University Of Miami School Of Medicine · P01 · FY2012 · AI
Development of New Antitumor Agents
$2,158,301Southern Research Institute · P01 · FY2003 · CA
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
$2,158,273Jean-Pierre J Issa · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA
A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in Botswana
$2,158,015Roger L Shapiro · Harvard School Of Public Health · U01 · FY2019 · AI
Targeting Enzymatic Regulation of Fetal Hemoglobin Repression
$2,157,816James Douglas Engel · University Of Michigan At Ann Arbor · P01 · FY2023 · HL
Mayo Clinic SPORE in Pancreatic Cancer
$2,157,728Gloria M. Petersen · Mayo Clinic Rochester · P50 · FY2016 · CA
Trial to Reduce IDDM in the Genetically at Risk -study
$2,157,583Mikael Knip · University Of Helsinki · U01 · FY2014 · HD
Biology & Transplantation of the Human Stem Cell
$2,157,390Philip McGlave · University Of Minnesota · P01 · FY2011 · CA